Find generic entry opportunities
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Manage your formulary budget
Proactively manage your pharmacy inventory
Anticipate generic drug launch
Drug patents …
… from Kazakhstan to Kalamazoo
|Title:||Method of reducing somnolence in patients treated with tizanidine|
|Abstract:||An article and method for reducing somnolence in a patient receiving tizanidine therapy. Tizanidine may be administered in the form of an immediate release multiparticulate composition at or around the time food is consumed. The composition may be packaged in a container for distribution.|
|Inventor(s):||Pellegrini; Cara A. (San Diego, CA), Stark; Paul (Westmeath, IE)|
|Assignee:||Elan Pharmaceuticals, Inc. (San Francisco, CA)|
Patent Claim Types:|
see list of patent claims
|Use; Composition; Formulation; Dosage form;|
Back Citations: 11th percentile
Forward Citations: 1st percentile
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|World Intellectual Property Organization (WIPO)||2005023252||► subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.